tiprankstipranks
Trending News
More News >
Rapport Therapeutics, Inc. (RAPP)
NASDAQ:RAPP
US Market

Rapport Therapeutics, Inc. (RAPP) Income Statement

Compare
34 Followers

Rapport Therapeutics, Inc. Income Statement

Last quarter (Q1 2025), Rapport Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Rapport Therapeutics, Inc.'s net income was $-24.06M. See Rapport Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22
Total Revenue
$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -112.00K$ -15.00K
Operating Expenses
$ 83.06M$ 36.07M$ 10.35M
Depreciation and Amortization
$ 839.00K$ 112.00K$ 15.00K
EBITDA
$ -77.47M$ -34.66M$ -10.35M
Operating Income
$ -83.06M$ -36.18M$ -10.37M
Other Income/Expenses
$ 4.75M$ 1.40M$ -285.00K
Pretax Income
$ -78.31M$ -34.78M$ -10.65M
Net Income
$ -78.31M$ -34.79M$ -10.65M
Per Share Metrics
Basic EPS
$ -0.38$ -0.19$ -0.05
Diluted EPS
$ -0.38$ -0.19$ -0.05
Weighted Average Shares Outstanding
207.38M--
Weighted Average Shares Outstanding (Diluted)
207.38M--
Currency in USD

Rapport Therapeutics, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis